Nicotinamide mononucleotide (NMN), a precursor of the coenzyme nicotinamide adenine dinucleotide (NAD+), has gained wide attention as an anti-aging agent, which plays a significant role in intracellular redox reactions. However, its effectiveness is limited by easy metabolism in the liver and subsequent excretion as nicotinamide, resulting in low bioavailability, particularly in the brain. Additionally, the blood-brain barrier (BBB) further hinders NMN supply to the brain, compromising its potential anti-aging effects. Herein, we developed a biocompatible polydopamine (PDA) platform to deliver NMN for boosting NAD+ levels in the brain for the first time. The lactoferrin (Lf) ligand was covalently attached to the PDA spheres to improve BBB transport efficiency. The resultant PDA-based system, referred to as PDA-Lf-NMN, not only exhibited superior BBB penetration ability but also improved the utilization rate of brain NMN in elevating NAD+ levels compared to NMN alone for both young (3 months) and old (21 months) mice. Moreover, after the old mice were treated with low-dose PDA-Lf-NMN (8 mg kg day), they exhibited improved spatial cognition. Importantly, these nanomedicines did not induce any cellular necrosis or apoptosis. It provides a promising avenue for delivering NMN specifically to the brain, boosting NAD+ levels for promoting longevity and treating brain aging-related diseases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/d4nr02934h | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Longer, the Better: Continuous Glucose Monitoring Use for ≥90% Is Superior to 70%-89% in Achieving Tighter Glycemic Outcomes in Children with Type 1 Diabetes.
Diabetes Technol Ther
January 2025
Department of Pediatrics, Motol University Hospital and 2 Faculty of Medicine, Prague, Czechia.
The recommended threshold for the time spent on continuous glucose monitoring (CGM) is established at 70%. However, glucose outcomes in children with type 1 diabetes (CwD) using CGM for a different proportion of time within this threshold have not been evaluated yet. The study aims to compare glycemic parameters among CwD who spent 70%-89% and ≥90% on CGM using the population-wide data from the Czech national pediatric diabetes registry ČENDA.
View Article and Find Full Text PDFAn electrochemical sensor integrated lab-on-a-CD system for phenylketonuria diagnostics.
Lab Chip
January 2025
Hacettepe University, Institute of Science, Nanotechnology and Nanomedicine Division, Ankara, Turkey.
Phenylketonuria (PKU) is characterized by an autosomal recessive mutation in the phenylalanine hydroxylase (PAH) gene. Impaired PAH enzyme activity leads to the accumulation of phenylalanine (Phe) and its metabolites in the bloodstream, which disrupts the central nervous system and causes psychomotor retardation. Early diagnosis of PKU is essential for timely intervention.
View Article and Find Full Text PDFMelittin inhibits MPP-induced HT22 cell death by suppressing Bax activation and improving mitochondrial function.
Korean J Physiol Pharmacol
January 2025
School of Preclinical Medicine, Wannan Medical College, Wuhu 241002, China.
Melittin (MEL) is the main bioactive component of bee venom and has been reported to have various pharmacological effects. This study investigates the protective effect of MEL on MPP-injured HT22 cells and the possible mechanisms involved. We treated the cells with 4 mM MPP for 24 h to induce a cellular injury model.
View Article and Find Full Text PDFReversing Signs of Parkinsonism in a Cell Model Using Mitochondria-Targeted Organoiridium Catalysis.
J Med Chem
January 2025
Department of Chemistry, University of Houston, 4800 Calhoun Rd., Houston, Texas 77204, United States.
We report the application of organoiridium complexes as catalytic agents for the detoxification of biogenic reactive aldehyde species (RASP), which are implicated in the pathogenesis of neurodegenerative disorders. We show that Ir complexes functionalized with phosphonium cations localize selectively in the mitochondria and have better cellular retention compared to that of their parent Ir species. In a cell model for Parkinsonism, the mitochondria-targeted iridium catalysts exhibited superior cell protecting abilities and longer-lasting effects (up to 6 d) than conventional RASP scavengers, which failed to be effective beyond 24 h.
View Article and Find Full Text PDFHighly Efficient Dual-Probe Strategy toward Single-Cell Metabolite Analysis.
Anal Chem
January 2025
School of Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, Nantong University, Nantong 226019, P. R. China.
Article Synopsis
- As cancer progresses, detached cells spread via the bloodstream, leading to complex metabolic changes that aid their survival and growth, yet the process of metastasis is still not fully understood.
- A new microfluidic platform utilizing a dual-probe strategy allows for the detection of metabolic changes at single-cell resolution, enabling researchers to analyze both intracellular and extracellular environments in detail.
- Findings indicate a positive relationship between increased intracellular NAD(P)H and higher levels of matrix metalloproteinases (MMPs), suggesting that these insights could aid in developing zinc-based treatments targeting cancer metastasis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!